• RDIF, Stelis Biopharma join hands for 200 mn doses of Sputnik V vaccine expresspharma
    March 22, 2021
    The Russian Direct Investment Fund (RDIF), and Stelis Biopharma, the biopharma division of Strides, have partnered to produce, and supply a minimum of 200 million doses of the Russian Sputnik V vaccine against coronavirus sufficient to vaccinate 100 ...
PharmaSources Customer Service